Cargando…

Initial rivaroxaban dosing in patients with atrial fibrillation

BACKGROUND: Rivaroxaban is a non‐vitamin K oral anticoagulant and has been approved for prevention of stroke and systemic embolism in patients with non‐valvular atrial fibrillation (AF). Current labeling recommends 20 mg once a day (q.d.) as a standard dose and a reduced dose of 15 mg q.d. in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ablefoni, Kaja, Buchholz, Alexander, Ueberham, Laura, Hilbert, Sebastian, Dagres, Nikolaos, Husser, Daniela, Hindricks, Gerhard, Bollmann, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788464/ https://www.ncbi.nlm.nih.gov/pubmed/31317562 http://dx.doi.org/10.1002/clc.23235

Ejemplares similares

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
por: Ueberham, Laura, et al.
Publicado: (2017)

Association of atrial fibrillation susceptibility genes, atrial fibrillation phenotypes and response to catheter ablation: a gene-based analysis of GWAS data
por: Husser, Daniela, et al.
Publicado: (2017)

Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2019)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Nedios, Sotirios, et al.
Publicado: (2021)

Genomic Contributors to Rhythm Outcome of Atrial Fibrillation Catheter Ablation – Pathway Enrichment Analysis of GWAS Data
por: Husser, Daniela, et al.
Publicado: (2016)

Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?
por: Nedios, Sotirios, et al.
Publicado: (2020)

Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation
por: Kornej, Jelena, et al.
Publicado: (2015)

PR Interval Associated Genes, Atrial Remodeling and Rhythm Outcome of Catheter Ablation of Atrial Fibrillation—A Gene-Based Analysis of GWAS Data
por: Husser, Daniela, et al.
Publicado: (2017)

Identification of Central Regulators of Calcium Signaling and ECM–Receptor Interaction Genetically Associated With the Progression and Recurrence of Atrial Fibrillation
por: Büttner, Petra, et al.
Publicado: (2018)

Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS data
por: Husser, Daniela, et al.
Publicado: (2016)

Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis
por: Eitel, Charlotte, et al.
Publicado: (2011)

Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation
por: Seewöster, Timm, et al.
Publicado: (2018)

The APPLE Score – A Novel Score for the Prediction of Rhythm Outcomes after Repeat Catheter Ablation of Atrial Fibrillation
por: Kornej, Jelena, et al.
Publicado: (2017)

Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation
por: Schumacher, Katja, et al.
Publicado: (2018)

Rate of acquired pulmonary vein stenosis after ablation of atrial fibrillation referred to electroanatomical mapping systems: Does it matter?
por: Schoene, Katharina, et al.
Publicado: (2019)

Sleep Disorders and Atrial Fibrillation: Current Situation and Future Directions
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2018)

Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillation
por: Husser, Daniela, et al.
Publicado: (2017)

Response of High-Sensitive C-Reactive Protein to Catheter Ablation of Atrial Fibrillation and Its Relation with Rhythm Outcome
por: Kornej, Jelena, et al.
Publicado: (2012)

Exercise and Atrial Fibrillation: Some Good News and Some Bad News
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2018)

Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation
por: Kornej, Jelena, et al.
Publicado: (2013)

Computed tomography model-based treatment of atrial fibrillation and atrial macro-re-entrant tachycardia
por: Piorkowski, Christopher, et al.
Publicado: (2008)

Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic
por: Husser, Daniela, et al.
Publicado: (2021)

Potential Contributors to Increased Pulmonary Embolism Hospitalizations During the COVID-19 Pandemic: Insights From the German-Wide Helios Hospital Network
por: Husser, Daniela, et al.
Publicado: (2021)

Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function
por: Nedios, Sotirios, et al.
Publicado: (2020)

Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany—An analysis of over 5 million patients
por: Husser, Daniela, et al.
Publicado: (2018)

Expected and observed in‐hospital mortality in heart failure patients before and during the COVID‐19 pandemic: Introduction of the machine learning‐based standardized mortality ratio at Helios hospitals
por: König, Sebastian, et al.
Publicado: (2021)

Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation
por: Gjermeni, Erind, et al.
Publicado: (2019)

Role of assist device implantation and heart transplantation in the long-term outcome of patients with structural heart disease after catheter ablation of ventricular tachycardia
por: Darma, Angeliki, et al.
Publicado: (2021)

P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis
por: Intzes, Stergios, et al.
Publicado: (2022)

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram
por: Husser, Daniela, et al.
Publicado: (2004)

Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score
por: Seewöster, Timm, et al.
Publicado: (2020)

Hospitalization deficit of in‐ and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID‐19 pandemic: Insights from the German‐wide helios hospital network
por: König, Sebastian, et al.
Publicado: (2021)

Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation
por: Kornej, Jelena, et al.
Publicado: (2014)

Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation
por: Kornej, Jelena, et al.
Publicado: (2018)

Rivaroxaban in atrial fibrillation
por: Giorgi, Mariano A, et al.
Publicado: (2012)

Patients’ attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation
por: Uhe, Tobias, et al.
Publicado: (2021)

C-kit(pos) cells in the human left atrial appendage
por: Schwarzkopf, Lea, et al.
Publicado: (2023)

Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study
por: Camm, A. John, et al.
Publicado: (2020)

Biatrial volume ratio predicts low voltage areas in atrial fibrillation
por: Seewöster, Timm, et al.
Publicado: (2021)

Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry
por: Kornej, Jelena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h4u88on5m08n04bblv6s615c78